Tracey Gager

<i>In vitro</i>and<i>in vivo</i>profile of SB 206553, a potent 5‐HT_2C/5‐HT_2Breceptor antagonist with anxiolytic‐like properties

G.A. Kennett, Martyn Wood, Fiona Bright et al. · British Journal of Pharmacology · 1996 · 240 citations · Full text

5-Chloro-<i>N</i>-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046):  A Potent, Selective, and Orally Bioavailable 5-HT₆ Receptor Antagonist

Steven M. Bromidge, Anthony M. Brown, Stephen E. Clarke et al. · Journal of Medicinal Chemistry · 1999 · 170 citations · Full text

Drug Target, Altmetric Attention Score, 4-Methoxy-3-piperazin-1-yl- Phenyl +18

Characterization of SB‐271046: A potent, selective and orally active 5‐HT₆ receptor antagonist

Carol Routledge, Steven M. Bromidge, Stephen F. Moss et al. · British Journal of Pharmacology · 2000 · 136 citations · Full text

Receptors Sb-271046, Pharmacotherapy, Experimental Pharmacology +16

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

Martyn Wood, Charlie Reavill, Brenda Trail et al. · Neuropharmacology · 2001 · 100 citations

Molecular Pharmacology, Withdrawal Anxiety, Psychiatry +11

Pharmacological characterisation of human 5-HT2 receptor subtypes

Jeffrey C. Jerman, Stephen Brough, Tracey Gager et al. · European Journal of Pharmacology · 2001 · 83 citations

Functional Selectivity, Medicine, Receptor (Biochemistry) +3